SPS
IMCR icon

Susquehanna Portfolio Strategies’s Immunocore IMCR Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
+49,179
New +$1.45M 0.02% 481
2026
Q1 		– Sell
-27,607
Closed -$958K – 1034
2025
Q4 		$958K Buy
27,607
+17,069
+162% +$603K 0.01% 658
2025
Q3 		$383K Buy
+10,538
New +$358K 0.01% 888

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Susquehanna Portfolio Strategies's IMCR Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Immunocore (IMCR) in Q2 2026: 49,179 shares worth $1.56M. The stake represents 0.02% of the portfolio and ranks #481 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in IMCR as recently as Q4 2025.

Susquehanna Portfolio Strategies first reported a position in IMCR in Q3 2025 and has held it in 3 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Susquehanna Portfolio Strategies held 49,179 shares of Immunocore worth $1.56M as of Q2 2026.
  • Immunocore was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Immunocore made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #481 holding.
  • Susquehanna Portfolio Strategies first reported a position in Immunocore in Q3 2025 and has held it in 3 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.